This Article Full Text (OnlineFirst PDF) All Versions of this Article: 0269881108089870v1 22/7/717    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Strougo, A Articles by Schoemaker, R C Search for Related Content PubMed PubMed Citation Articles by Strougo, A Articles by Schoemaker, R C Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB TETRAHYDROCANNABINOL Social Bookmarking                         What's this?

Modelling of the concentration–effect relationship of THC on central nervous system parameters and heart rate – insight into its mechanisms of action and a tool for clinical research and development of cannabinoids

¹ Centre for Human Drug Research, Statistics, Leiden, The Netherlands
² Centre for Human Drug Research, Pharmacology CNS, Leiden, The Netherlands
³ Sanofi-Aventis, Recherche-Développement, Paris, France

^* To whom correspondence should be addressed.

	Abstract

Abstract

Pharmacokinetics after pulmonary administration of -9-tetrahydrocannabinol (THC) and its major metabolites 11-OH-THC and 11-nor-9-COOH-THC was quantified. Additionally, the relationship between THC and its effects on heart rate, body sway and several visual analogue scales was investigated using pharmacokinetic–pharmacodynamic (PK-PD) modelling. This provided insights useful for the research and development of novel cannabinoids and the physiology and pharmacology of cannabinoid systems. First, the PK-PD model gave information reflecting various aspects of cannabinoid systems. The delay between THC concentration and effect was quantified in equilibration half-lives of 7.68 min for heart rate and from 39.2 to 84.8 min for the CNS responses. This suggests that the effect of THC on the different responses could be due to different sites of action or different physiological mechanisms. Differences in the shape of the concentration–effect relationship could indicate various underlying mechanisms. Second, the PK-PD model can be used for prediction of THC concentration and effect profiles. It is illustrated how this can be used to optimise studies with entirely different trial designs. Third, many new cannabinoid agonists and antagonists are in development. PK-PD models for THC can be used as a reference for new agonists or as tools to quantitate the pharmacological properties of cannabinoid antagonists.

Key Words: THC, 11-OH-THC, 11-nor-9-COOH-THC, metabolites, NONMEM, nonlinear mixed effect modelling, visual analogue scale, heart rate, body sway

First published on June 26, 2008, doi:10.1177/0269881108089870

Journal of Psychopharmacology 2008;22:717.

A more recent version of this article appeared on September 1, 2008


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?